Skip to main content
. Author manuscript; available in PMC: 2014 Oct 24.
Published in final edited form as: J Med Chem. 2013 Oct 10;56(20):10.1021/jm401266k. doi: 10.1021/jm401266k

Table 3.

Inhibition of CYP3A4.

Cmpd IC50a % TDIb kobsc kobs ratiod
4 0.34 66 0.0921 6.01
5 > 50 4 0.0023 0.11
8 > 50 3 0.0003 0.01
10 1.1 < 1 0.0028 0.15
11 0.04 36 0.0386 1.78
a

inhibition of midazolam turnover, μM

b

normalized percent activity remaining (12 min preincubation with cmpd at 10 μM)

c

inactivation rate, min−1

d

ratio of inactivation rates between compound and ethynylestradiol (< 1 considered low TDI potential).